Canadian Researchers Launch Study to Make Stem Cell Transplants Safer, More Efficient
Researchers in Canada are studying how to reduce the risks associated with the treatment of multiple myeloma by improving the safety and efficacy of…
News
MS Therapy May Ease Painful Side Effect of Velcade Treatment in Myeloma Patients, Study Says
A multiple sclerosis (MS) treatment reduced a common painful side effect of Velcade (bortezomib) in a mouse model, suggesting that it might help…
Update on bb2121, Potential Advanced Multiple Myeloma Therapy, Set for ASCO 2018
Celgene’s investigational and second-generation CAR T-cell therapy bb2121 is showing real promise in treating advanced multiple myeloma patients, those with relapsed or refractory disease, updated…
Recruitment Open for Phase 2 Trial Aimed at Complete Eradication of Myeloma Cells
The University of Alabama at Birmingham (UAB) is recruiting patients with newly diagnosed multiple myeloma for a Phase 2 trial evaluating an…
FDA Names Cancer Vaccine Galinpepimut-S Orphan Drug as Possible Multiple Myeloma Treatment
The investigational cancer vaccine galinpepimut-S (GPS) has been designated an orphan drug by the U.S. Food and Drug Administration as a possible treatment of…
FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients
The U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in combination with standard therapy for the treatment of patients with newly-diagnosed multiple myeloma who…
Selinexor May Bring Hope to Heavily Treated Myeloma Patients, Trial Results Show
A quarter of heavily treated patients with penta-refractory multiple myeloma responded to Karyopharm‘s investigative oral therapy selinexor (KPT-330), according to top-line data from…
9/11 Firefighters at Greater Risk of Multiple Myeloma Precursor, Study Reports
New York City firefighters exposed to the 9/11 World Trade Center (WTC) disaster are at greater risk for developing a condition called monoclonal gammopathy of…
Stand Up to Cancer Awards $10 Million to ‘Dream Team’ Focused on Early Detection of Precursor Multiple Myeloma Conditions
Stand Up to Cancer (SU2C) recently awarded $10 million to a SU2C Dream Team that wants to move the treatment of multiple myeloma from…
Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say
Researchers say they have developed a low-cost, reliable, chip-based blood test to detect multiple myeloma, which could replace the painful bone marrow biopsy. Their…
